HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

H A Ghofrani Selected Research

motapizone

2/2000Subthreshold doses of specific phosphodiesterase type 3 and 4 inhibitors enhance the pulmonary vasodilatory response to nebulized prostacyclin with improvement in gas exchange.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


H A Ghofrani Research Topics

Disease

34Pulmonary Hypertension
03/2015 - 02/2000
21Pulmonary Arterial Hypertension
04/2019 - 04/2002
6Hypoxia (Hypoxemia)
03/2012 - 08/2000
5Heart Failure
05/2012 - 03/2000
5Familial Primary Pulmonary Hypertension
10/2008 - 01/2000
4Vascular Remodeling
03/2012 - 06/2000
3Disease Progression
04/2019 - 12/2001
3Hypertension (High Blood Pressure)
12/2006 - 09/2006
2Chronic Obstructive Pulmonary Disease (COPD)
05/2013 - 08/2009
2Lung Diseases (Lung Disease)
04/2011 - 10/2010
2Inflammation (Inflammations)
01/2011 - 04/2009
2Hypotension (Low Blood Pressure)
10/2010 - 06/2000
2Cardiomegaly (Heart Hypertrophy)
10/2008 - 03/2008
2Thrombosis (Thrombus)
11/2002 - 06/2000
2Fibrosis (Cirrhosis)
03/2000 - 03/2000
1Epistaxis (Nosebleed)
04/2019
1Hemorrhage
04/2019
1Hereditary Hemorrhagic Telangiectasia
04/2019
1Idiopathic Pulmonary Fibrosis
05/2013
1Infarction (Infarctions)
01/2011
1Infections
01/2011
1Rupture
01/2011
1Thromboembolism
11/2009
1Arteriovenous Malformations (Arteriovenous Malformation)
11/2009
1Interstitial Lung Diseases (Interstitial Lung Disease)
04/2009
1Hyperoxia
04/2009
1Bronchopulmonary Dysplasia
04/2009
1Autoimmune Hepatitis
09/2006
1Alcoholic Liver Diseases (Alcoholic Liver Disease)
09/2006
1Hepatitis
09/2006
1HIV Infections (HIV Infection)
02/2004
1Respiratory Insufficiency (Respiratory Failure)
08/2003
1Vascular Diseases (Vascular Disease)
03/2000

Drug/Important Bio-Agent (IBA)

10Iloprost (Ventavis)FDA Link
07/2009 - 01/2000
10Epoprostenol (Prostacyclin)FDA LinkGeneric
01/2006 - 03/2000
9ProstaglandinsIBA
04/2011 - 06/2000
7Vasodilator Agents (Vasodilators)IBA
05/2012 - 03/2000
6Endothelin Receptor AntagonistsIBA
04/2011 - 12/2006
6Phosphodiesterase 5 InhibitorsIBA
04/2011 - 08/2001
615-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic AcidIBA
08/2003 - 02/2000
5riociguatIBA
03/2015 - 10/2008
5Soluble Guanylyl CyclaseIBA
10/2010 - 08/2000
5Sildenafil Citrate (Viagra)FDA Link
11/2007 - 11/2002
4Oxygen (Dioxygen)IBA
08/2009 - 03/2000
4Phosphodiesterase InhibitorsIBA
08/2009 - 11/2001
4Type 5 Cyclic Nucleotide PhosphodiesterasesIBA
07/2008 - 08/2000
4ThromboxanesIBA
11/2001 - 02/2000
3Phosphoric Diester Hydrolases (Phosphodiesterases)IBA
04/2009 - 08/2003
3Nitric Oxide (Nitrogen Monoxide)FDA Link
04/2009 - 01/2000
2Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA
04/2019 - 12/2001
2DiureticsIBA
05/2012 - 12/2001
2NADPH Oxidases (NAD(P)H oxidase)IBA
03/2012 - 04/2001
2MonocrotalineIBA
05/2011 - 03/2008
2Guanosine Monophosphate (5' Guanylic Acid)IBA
04/2002 - 08/2000
2AnticoagulantsIBA
12/2001 - 06/2000
2Guanylate Cyclase (Guanylyl Cyclase)IBA
08/2001 - 08/2000
2Superoxides (Superoxide)IBA
10/2000 - 08/2000
1Activin Receptors (Activin Receptor)IBA
04/2019
1Tacrolimus (Prograf)FDA LinkGeneric
04/2019
1N 30IBA
05/2013
1Clostridium perfringens epsilon-toxinIBA
05/2013
1Reactive Oxygen Species (Oxygen Radicals)IBA
03/2012
1acetovanillone (apocynin)IBA
03/2012
1Proteins (Proteins, Gene)FDA Link
03/2012
1Small Interfering RNA (siRNA)IBA
03/2012
1Serotonin (5 Hydroxytryptamine)IBA
05/2011
1dironyl (terguride)IBA
05/2011
1CytokinesIBA
01/2011
1ChemokinesIBA
01/2011
1rho-Associated KinasesIBA
10/2010
1EndoglinIBA
11/2009
1prednylidene (Pred)IBA
11/2009
1Tyrosine Kinase InhibitorsIBA
08/2009
1Endothelin-1 (Endothelin 1)IBA
06/2009
1Type 4 Cyclic Nucleotide PhosphodiesterasesIBA
04/2009
1Messenger RNA (mRNA)IBA
04/2009
1pumafentrineIBA
03/2008
1Endothelin Receptors (Endothelin Receptor)IBA
12/2006
1Drug CombinationsIBA
12/2006
1Pharmaceutical PreparationsIBA
12/2006
1zardaverineIBA
08/2003
1Transforming Growth Factor beta Receptors (TGF beta Receptors)IBA
12/2001
1Calcium Channel Blockers (Blockers, Calcium Channel)IBA
12/2001
1Transforming Growth Factor beta (TGF-beta)IBA
12/2001
1Atrial Natriuretic Factor (ANF)IBA
10/2001
1Dipyridamole (Persantine)FDA LinkGeneric
08/2001
1Natriuretic PeptidesIBA
08/2001
1UlaritideIBA
08/2001
1diphenyleneiodoniumIBA
04/2001
1Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
10/2000
16-anilino-5,8-quinolinedioneIBA
08/2000
1Vasoconstrictor AgentsIBA
08/2000
1Methylene Blue (Methylthioninium Chloride)FDA Link
08/2000
1zaprinastIBA
08/2000
1Fibrinolytic Agents (Antithrombotic Agents)IBA
06/2000

Therapy/Procedure

22Therapeutics
09/2017 - 03/2000
3Endarterectomy (Thromboendarterectomy)
05/2012 - 11/2007
1Critical Care (Surgical Intensive Care)
05/2012
1Septal Occluder Device
01/2011
1Drug Tapering
10/2010